US2021079351A1PendingUtilityA1

Tissue-specific differentiation matrices and uses thereof

Assignee: UNIV TEXASPriority: Sep 7, 2010Filed: May 15, 2020Published: Mar 18, 2021
Est. expirySep 7, 2030(~4.1 yrs left)· nominal 20-yr term from priority
Inventors:Xiao-Dong Chen
C12N 5/0663C12N 2501/06C12N 5/0657C12N 2533/52C12N 2502/1323C12N 2501/115C12N 5/0665C12N 2533/90A61K 35/34C12N 5/0662A61K 35/28C12N 5/0605
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

In some aspects, this invention provides a method of making a bone marrow-derived tissue-specific stem cell proliferation, expansion, isolation and rejuvenation extracellular matrix. In other aspects, this invention provides a method of making a tissue-specific fibroblast-derived stem cell differentiation extracellular matrix. Also provided are methods of using such a cell-derived preservation or differentiation matrices to induce tissue-specific differentiation of pluripotent cells, repair damaged tissue, and treat a subject having a physiologic deficiency using the same.

Claims

exact text as granted — not AI-modified
1 .- 48 . (canceled) 
     
     
         49 . A method of treating a subject having a physiologic deficiency comprising:
 a) contacting a sample containing MSCs with a rejuvenating matrix to produce rejuvenated MSCs; and   b) introducing the rejuvenated MSCs into the subject,   wherein the physiologic deficiency is treated.   
     
     
         50 . The method of  claim 49 , wherein the sample is a human or murine sample. 
     
     
         51 . The method of  claim 49 , wherein the rejuvenating matrix is a preservation matrix generated by bone marrow cells obtained from a subject that is younger than the subject having a physiologic deficiency. 
     
     
         52 . The method of  claim 51 , wherein the subject is an elderly subject suffering from one or more of osteopenia, osteoporosis, sarcopenia and cachexia. 
     
     
         53 . The method of  claim 49 , wherein the rejuvenating matrix is a 3D rejuvenating matrix. 
     
     
         54 .- 106 . (canceled)

Join the waitlist — get patent alerts

Track US2021079351A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.